UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Alibaba
BABA
|
+$624M |
| 2 |
Microsoft
MSFT
|
+$360M |
| 3 |
Accenture
ACN
|
+$249M |
| 4 |
Walmart
WMT
|
+$205M |
| 5 |
Mastercard
MA
|
+$198M |
Top Sells
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$329M |
| 2 |
CELG
Celgene Corp
CELG
|
+$293M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$220M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$188M |
| 5 |
JPMorgan Chase
JPM
|
+$173M |
Sector Composition
| 1 | Technology | 19.83% |
| 2 | Financials | 14.05% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
IDEX
IEX
$12.4B
| $59.8M | 0.04% |
347,389
+25,759
| +8% | +$4.43M |
|
477
Vulcan Materials
VMC
$39.5B
| $59.7M | 0.04% |
414,791
+7,313
| +2% | +$1.05M |
|
478
Kohl's
KSS
$1.86B
| $59.6M | 0.04% |
1,169,144
-19,068
| -2% | -$972K |
|
479
NVR
NVR
$23.6B
| $58.5M | 0.04% |
15,372
+943
| +7% | +$3.59M |
|
480
Huntington Bancshares
HBAN
$25.9B
| $58.5M | 0.04% |
3,877,758
+90,074
| +2% | +$1.36M |
|
481
Sarepta Therapeutics
SRPT
$1.84B
| $58.3M | 0.04% |
451,473
+58,372
| +15% | +$7.53M |
|
482
Wolfspeed
WOLF
$192M
| $58.1M | 0.04% |
1,259,262
+310,182
| +33% | +$14.3M |
|
483
Hologic
HOLX
$14.8B
| $57.7M | 0.04% |
1,104,411
+12,135
| +1% | +$634K |
|
484
F5
FFIV
$18.4B
| $57.6M | 0.04% |
412,437
-102,773
| -20% | -$14.4M |
|
485
Robert Half
RHI
$3.66B
| $57.5M | 0.04% |
911,262
+52,078
| +6% | +$3.29M |
|
486
Ingredion
INGR
$8.22B
| $57.5M | 0.04% |
619,024
-49,780
| -7% | -$4.63M |
|
487
Kimco Realty
KIM
$15.3B
| $57.4M | 0.04% |
2,771,727
+43,790
| +2% | +$907K |
|
488
SL Green Realty
SLG
$4.32B
| $57.3M | 0.04% |
644,632
-161,324
| -20% | -$14.3M |
|
489
Lennar Class A
LEN
$36.9B
| $57.1M | 0.04% |
1,057,630
+35,671
| +3% | +$1.93M |
|
490
Southwest Airlines
LUV
$16.7B
| $57.1M | 0.04% |
1,057,943
+98,755
| +10% | +$5.33M |
|
491
Expedia Group
EXPE
$26.9B
| $56.1M | 0.03% |
519,086
-470,214
| -48% | -$50.8M |
|
492
HubSpot
HUBS
$26.3B
| $56.1M | 0.03% |
353,849
+222,098
| +169% | +$35.2M |
|
493
Vale
VALE
$44.6B
| $56M | 0.03% |
4,242,585
+267,760
| +7% | +$3.53M |
|
494
Exact Sciences
EXAS
$10.2B
| $55.8M | 0.03% |
603,596
+69,268
| +13% | +$6.41M |
|
495
TechnipFMC
FTI
$16.1B
| $55.4M | 0.03% |
3,475,409
+438,907
| +14% | +$7M |
|
496
Neurocrine Biosciences
NBIX
$14.3B
| $55.1M | 0.03% |
512,289
+103,841
| +25% | +$11.2M |
|
497
W.R. Berkley
WRB
$27.5B
| $54.8M | 0.03% |
1,783,730
-190,987
| -10% | -$5.87M |
|
498
Teleflex
TFX
$5.75B
| $54.5M | 0.03% |
144,893
+5,372
| +4% | +$2.02M |
|
499
Fox Class A
FOXA
$27.8B
| $54.5M | 0.03% |
1,471,229
-60,437
| -4% | -$2.24M |
|
500
Martin Marietta Materials
MLM
$37.8B
| $54.5M | 0.03% |
194,821
-3,946
| -2% | -$1.1M |
|